EMBRACING
HEALTH

About us

Cevomed acts as a portal paving the way for international pharmaceutical and biotech companies striving to access the MEA healthcare market and it forms as well a link through its distinguished business model in the region between patients and evolutionary health solutions.

read more

EMBRACING
HEALTH

Mission & Vision

We are aiming to be a trusted reference in the MEA region for both patients & partners through our commitment of bringing the highest quality innovative products and health solutions. Cevomed provides the ultimate care for patients and partners need through following cohesively the continuous evolution in health sector.

read more

EMBRACING
HEALTH

Values

Ours values reflect our corporate believes and understanding as they represent the pillars and the corner stones of all our interactions internally and externally.We Take personal accountability for all our actions and results always focusing on finding solutions and achieving results overcoming all the hurdles on the way.

read more

OPHTHALMOLOGY

In many middle-income and industrialized countries, three other eye conditions have emerged as potential threats to the status of sight of their populations. The increase of diabetes among many population groups has caused diabetic retinopathy to be added to the priority list, while glaucoma, an eye disease known for centuries, remains on the public health agenda due to difficulties in its early diagnosis and frequent necessity of life-long treatment. Age-related macular degeneration (AMD) ranks third among the global causes of visual impairment with a blindness prevalence of 8,7%. It is the primary cause of visual deficiency in industrialized countries. An emerging important cause of visual impairment is uncorrected refractive errors. According to WHO prevention of blindness and visual impairment program.

Oftalmica has been the pioneer in launching several innovative ophthalmic products in its territory, becoming into the most complete and modern line in the specialty. The manufacturing plant where Oftalmica and other lines industrialize its products has more than 9.000 square meters and complies with GMP (Good Manufacturing Practices) requirements and international guidelines
;